Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP49690.RAQKu8qeMcpzjGd2yC_AMa4kaOZmp4fx-dQS2_RBctpzA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP49690.RAQKu8qeMcpzjGd2yC_AMa4kaOZmp4fx-dQS2_RBctpzA130_assertion type Assertion NP49690.RAQKu8qeMcpzjGd2yC_AMa4kaOZmp4fx-dQS2_RBctpzA130_head.
- NP49690.RAQKu8qeMcpzjGd2yC_AMa4kaOZmp4fx-dQS2_RBctpzA130_assertion description "[We conclude that low serum 1,25-D3 levels, at least in part, account for the decrease in VDR content in parathyroid glands of uremic rats and that treatment with 1,25-D3 or OCT prevents this decrease ameliorating the development of secondary hyperparathyroidism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP49690.RAQKu8qeMcpzjGd2yC_AMa4kaOZmp4fx-dQS2_RBctpzA130_provenance.
- NP49690.RAQKu8qeMcpzjGd2yC_AMa4kaOZmp4fx-dQS2_RBctpzA130_assertion evidence source_evidence_predicted NP49690.RAQKu8qeMcpzjGd2yC_AMa4kaOZmp4fx-dQS2_RBctpzA130_provenance.
- NP49690.RAQKu8qeMcpzjGd2yC_AMa4kaOZmp4fx-dQS2_RBctpzA130_assertion SIO_000772 8807569 NP49690.RAQKu8qeMcpzjGd2yC_AMa4kaOZmp4fx-dQS2_RBctpzA130_provenance.
- NP49690.RAQKu8qeMcpzjGd2yC_AMa4kaOZmp4fx-dQS2_RBctpzA130_assertion wasDerivedFrom rgd-20150221 NP49690.RAQKu8qeMcpzjGd2yC_AMa4kaOZmp4fx-dQS2_RBctpzA130_provenance.
- NP49690.RAQKu8qeMcpzjGd2yC_AMa4kaOZmp4fx-dQS2_RBctpzA130_assertion wasGeneratedBy ECO_0000218 NP49690.RAQKu8qeMcpzjGd2yC_AMa4kaOZmp4fx-dQS2_RBctpzA130_provenance.